NCT06760481 2026-04-15
Phase I/Ib Trial of TIraGolumab, AtEzolizumab, and RadScopal Radiation in Patients With Advanced Solid Malignancies (TIGER)
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
M.D. Anderson Cancer Center
AstraZeneca
Biocity Biopharmaceutics Co., Ltd.
BioRay Pharmaceutical Co., Ltd.
Georgiamune Inc
Treadwell Therapeutics, Inc